| Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial K Wenke, B Meiser, J Thiery, D Nagel, W von Scheidt, G Steinbeck, ... Circulation 96 (5), 1398-1402, 1997 | 593 | 1997 |
| Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label … D Sibbing, D Aradi, C Jacobshagen, L Gross, D Trenk, T Geisler, M Orban, ... The Lancet 390 (10104), 1747-1757, 2017 | 568 | 2017 |
| Cardiac allograft vasculopathy: a review M Weis, W von Scheidt Circulation 96 (6), 2069-2077, 1997 | 559 | 1997 |
| Simvastatin initiated early after heart transplantation: 8-year prospective experience K Wenke, B Meiser, J Thiery, D Nagel, W von Scheidt, K Krobot, ... Circulation 107 (1), 93-97, 2003 | 293 | 2003 |
| Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: importance of mycophenolic acid therapeutic drug monitoring BM Meiser, M Pfeiffer, D Schmidt, H Reichenspurner, P Ueberfuhr, ... The Journal of heart and lung transplantation 18 (2), 143-149, 1999 | 192 | 1999 |
| Simvastatin treatment is associated with improvement in coronary endothelial function and decreased cytokine activation in patients after heart transplantation M Weis, S Pehlivanli, BM Meiser, W von Scheidt Journal of the American College of Cardiology 38 (3), 814-818, 2001 | 169 | 2001 |
| The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial … K Tsuchida, A Colombo, T Lefevre, KG Oldroyd, V Guetta, G Guagliumi, ... European heart journal 28 (4), 433-442, 2007 | 165 | 2007 |
| Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy G Vassalli, A Gallino, M Weis, W Von Scheidt, L Kappenberger, ... European heart journal 24 (13), 1180-1188, 2003 | 165 | 2003 |
| Amiodarone-induced pulmonary toxicity: an under-recognized and severe adverse effect? M Schwaiblmair, T Berghaus, T Haeckel, T Wagner, W von Scheidt Clinical Research in Cardiology 99 (11), 693-700, 2010 | 131 | 2010 |
| Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function P Petrakopoulou, M Kübrich, S Pehlivanli, B Meiser, B Reichart, ... Circulation 110 (11_suppl_1), II-207-II-212, 2004 | 131 | 2004 |
| Coronary artery disease in the transplanted heart M Weis, W Von Scheidt Annual review of medicine 51 (1), 81-100, 2000 | 113 | 2000 |
| Temporal variations in the triggering of myocardial infarction by air temperature in Augsburg, Germany, 1987–2014 K Chen, S Breitner, K Wolf, R Hampel, C Meisinger, M Heier, ... European heart journal 40 (20), 1600-1608, 2019 | 112 | 2019 |
| Functional significance of cardiac reinnervation in heart transplant recipients M Schwaiblmair, W von Scheidt, P Überfuhr, S Ziegler, M Schwaiger, ... The Journal of Heart and Lung Transplantation 18 (9), 838-845, 1999 | 108 | 1999 |
| Ventilatory efficiency testing as prognostic value in patients with pulmonary hypertension M Schwaiblmair, C Faul, W von Scheidt, TM Berghaus BMC pulmonary medicine 12, 1-7, 2012 | 106 | 2012 |
| 20‐year trends in clinical characteristics, therapy and short‐term prognosis in acute myocardial infarction according to presenting electrocardiogram: the MONICA/KORA AMI … B Kuch, M Heier, W Von Scheidt, B Kling, A Hoermann, C Meisinger Journal of internal medicine 264 (3), 254-264, 2008 | 99 | 2008 |
| The patient’s interpretation of myocardial infarction symptoms and its role in the decision process to seek treatment: the MONICA/KORA Myocardial Infarction Registry I Kirchberger, M Heier, R Wende, W von Scheidt, C Meisinger Clinical Research in Cardiology 101, 909-916, 2012 | 95 | 2012 |
| Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial A Bauer, M Schreinlechner, N Sappler, T Dolejsi, H Tilg, BA Aulinger, ... The Lancet Respiratory Medicine 9 (8), 863-872, 2021 | 93 | 2021 |
| Aggressive lowering of fibrinogen and cholesterol in the prevention of graft vessel disease after heart transplantation BR Jaeger, B Meiser, D Nagel, P Überfuhr, J Thiery, U Brandi, W Brückner, ... Circulation 96 (9), 154-158, 1997 | 80 | 1997 |
| Fluoroscopy-Guided Aortic Root Imaging for TAVR: “Follow the Right Cusp” Rule AM Kasel, S Cassese, AW Leber, W von Scheidt, A Kastrati JACC: Cardiovascular Imaging 6 (2), 274-275, 2013 | 76 | 2013 |
| Sex and age specific time patterns and long term time trends of pre-hospital delay of patients presenting with acute ST-segment elevation myocardial infarction KH Ladwig, C Meisinger, H Hymer, K Wolf, M Heier, W von Scheidt, ... International journal of cardiology 152 (3), 350-355, 2011 | 75 | 2011 |
